| PTK2 (FAK) | FAK | TK | 2etm | A | | 7-pyridin-2-yl-n-(3,4,5-trimethoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-2-amine | Human | 246 | 1.00 | |
| CDK2 | CDK | CMGC | 3eoc | C | | 5-methyl-7-phenyl-n-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine | Human | 3969 | 0.45 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 7zwe | A | B | 7-(1~{h}-indol-2-yl)-5-methyl-~{n}-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine | Human | 14771 | 0.42 | |
| CSNK2A1 (CK2a1) | CK2 | CMGC | 7zwe | A | A | 7-(1~{h}-indol-2-yl)-5-methyl-~{n}-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine | Human | 14775 | 0.42 | |
| CDK2 | CDK | CMGC | 3eoc | A | | 5-methyl-7-phenyl-n-(3,4,5-trimethoxyphenyl)imidazo[5,1-f][1,2,4]triazin-2-amine | Human | 4390 | 0.45 | |
| EPHB4 (EphB4) | Eph | TK | 2vwv | A | B | n'-(3-chloro-4-methoxy-phenyl)-n-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine | Human | 369 | 0.45 | |
| EPHB4 (EphB4) | Eph | TK | 2vwv | A | A | n'-(3-chloro-4-methoxy-phenyl)-n-(3,4,5-trimethoxyphenyl)-1,3,5-triazine-2,4-diamine | Human | 365 | 0.45 | |
| KDR | VEGFR | TK | 3cjf | A | B | n~4~-(3-methyl-1h-indazol-6-yl)-n~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | Human | 6794 | 0.40 | |
| LCK | Src | TK | 3bym | A | | n-phenyl-1-{4-[(3,4,5-trimethoxyphenyl)amino]-1,3,5-triazin-2-yl}-1h-benzimidazol-2-amine | Human | 2264 | 0.42 | |
| ULK2 | ULK | Other | 6yid | D | B | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12383 | 0.45 | |
| ULK2 | ULK | Other | 6yid | A | A | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12385 | 0.45 | |
| ULK2 | ULK | Other | 6yid | D | A | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12388 | 0.45 | |
| ULK2 | ULK | Other | 6yid | C | B | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12386 | 0.45 | |
| PRKAA2 (AMPKa2) | CAMKL | CAMK | 6bx6 | A | B | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 9877 | 0.45 | |
| PRKAA2 (AMPKa2) | CAMKL | CAMK | 6bx6 | A | A | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 9878 | 0.45 | |
| ULK2 | ULK | Other | 6yid | B | B | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12387 | 0.45 | |
| ULK2 | ULK | Other | 6yid | B | A | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12381 | 0.45 | |
| PTK2 (FAK) | FAK | TK | 2etm | B | | 7-pyridin-2-yl-n-(3,4,5-trimethoxyphenyl)-7h-pyrrolo[2,3-d]pyrimidin-2-amine | Human | 225 | 1.00 | |
| KDR | VEGFR | TK | 3cjf | A | A | n~4~-(3-methyl-1h-indazol-6-yl)-n~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine | Human | 6792 | 0.40 | |
| KDR | VEGFR | TK | 2p2h | A | | 4-(2-anilinopyridin-3-yl)-n-(3,4,5-trimethoxyphenyl)-1,3,5-triazin-2-amine | Human | 5310 | 0.48 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 6qy9 | A | A | 3-[3-[2-[(3,4,5-trimethoxyphenyl)amino]pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]propanenitrile | Human | 11012 | 0.59 | |
| CSNK2A2 (CK2a2) | CK2 | CMGC | 6qy9 | A | B | 3-[3-[2-[(3,4,5-trimethoxyphenyl)amino]pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]propanenitrile | Human | 11011 | 0.59 | |
| ULK2 | ULK | Other | 6yid | A | B | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12382 | 0.45 | |
| ULK2 | ULK | Other | 6yid | C | A | 2-({5-bromo-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}oxy)-n-methylbenzene-1-carboximidic acid | Human | 12384 | 0.45 | |
